1
of lymphocyte cultures at baseline or 3dpi representing ~500,000 cells were pelleted at 1 0 5 1400 rpm for 3 minutes into 96-well round bottom plates. Cells were resuspended in 1 0 6 100µl PBS containing (0.4ng/ml) fixable viability stain (BD Cat# 564406) and incubated 1 0 7 on ice for 15 minutes. Cells were pelleted and resuspended in 100µl cold PBS without 1 0 8 calcium and magnesium containing 2% FBS,0.5% BSA (FACS Block) and incubated on 1 0 9 ice for 10 minutes after which 100µl cold PBS containing 0.5% BSA and 0.1% Sodium 1 1 0 Azide (FACS Wash) was added. Cells were pelleted and resuspended in FACS Wash 1 1 1 containing B cell phenotype panel as follows for 15 minutes on ice: (volumes indicated 1 1 2 were routinely used for up to 0.5(10)^6 cells and were based on titration of the individual 1 1 3 antibodies on primary tonsil lymphocyte specimens) CD19-PerCPCy5.5 (2.5µl, BD 1 1 4 561295), CD20-PE-Cy7 (2.5ul, BD 560735), CD38-APC (10µl, BD 555462), IgD-APC-1 1 5 H7 (2.5µl, BD 561305), CD138-v450 (2.5µl, BD 562098), CD27-PE (10µl BD 555441). 1 1 6
After incubation, 150µl FACS Wash was added and pelleted lymphocytes were washed 1 1 7 with a further 200µl of FACS Wash prior to being resuspended in 200µl FACS Wash for 1 1 8
analysis. Data was acquired on a BD FACS VERSE Flow Cytometer and analyzed 1 1 9
using FlowJo software. Readers should note that the BD FACS VERSE analysis 1 2 0 instrument lacks a 561nm laser so RFP lytic reporter expression from the KSHV.219 1 2 1 genome is not detectable in the PE channel. For baseline T cell frequencies 0.5e6 cells 1 2 2 from baseline uninfected total lymphocyte samples were stained and analyzed as above 1 2 3 with phenotype antibody panel as follows: CD95-APC (2µl, Biolegend 305611), CCR7-1 2 4 PE (2µl, BD 566742), CD28-PE Cy7 (2µl, Biolegend 302925), CD45RO-FITC (3µl, 1 2 5
Biolegend 304204), CD45RA-PerCP Cy5.5 (2µl, 304121), CD4-APC H7 (2µl, BD 1 2 6 560158), CD19-V510 (3µl, BD 562953), CD8-V450 (2.5µl, BD 561426) 1 2 7 KSHV neutralization via soluble Syndecan-1. Infections were performed as described 1 2 8 above except KSHV.219 virus was pre-incubated for 30 minutes on ice with serum free 1 2 9 RPMI only or serum free RPMI containing recombinant human syndecan-1 protein 1 3 0 (rhCD138, BioVision, 7879-10) prior to being added to Naïve B lymphocytes. rhCD138 1 3 1 concentrations noted in the text indicate the final concentration of recombinant 1 3 2 syndecan-1 in the reconstituted total lymphocyte culture. Infection was analyzed at 3 1 3 3 days post-infection by flow cytometry for B cell lineages and KSHV infection as detailed 1 3 4 above. For experiments involving human fibroblasts virus was added to cells in serum 1 3 5 free media, cells were spinoculated for 30 minutes at 1000rpm, incubated at 37˚C for 1 1 3 6 hour, then infection media was removed and replaced with complete media. At 3dpi 1 3 7 cells were harvested via trypsinization and analyzed for infection by flow cytometry. 1 3 8 T cell depletion studies. Infections were performed as described above except a sub-1 3 9 population of total lymphocytes were depleted of either CD4 or CD8 T cells using 1 4 0 positive selection magnetic beads (MojoSort™ Human CD4 T Cell Isolation Kit 1 4 1
Cat#480009, MojoSort™ Human CD8 T Cell Isolation Kit Cat#480011). The resulting 1 4 2 depleted fractions or unmanipulated total lymphocytes were used to reconstitute naïve 1 4 3 B lymphocytes following infection rather than bound lymphocyte fractions as described In order to explore the B cell lineages targeted by KSHV infection in human tonsil, we 1 5 3 procured a cohort of 40 de-identified human tonsil specimens from donors of diverse 1 5 4 age, sex and self-reported race ( Figure 1A ). Analysis of the baseline frequencies of 1 5 5 individual B cell lineages by multi-color flow cytometry (Supplemental Figure 1A ) 1 5 6 revealed that the composition of individual human tonsil specimens is highly variable 1 5 7 ( Figure 1B ). This variation was independent of donor age for many lineages. However, 1 5 8 overall B cell frequencies declined with age as did germinal center, plasmablast and 1 5 9 transitional B cell populations while memory and naïve populations increased in 1 6 0 frequency with donor age ( Figure 1C ). 1 6 1
Variable susceptibility of tonsil-derived B cells to ex vivo KSHV infection. 1 6 2
Because of the heterogeneous nature of the samples, we predicted that each sample 1 6 3 would also have variable levels of susceptible B cell subtypes. Therefore, we employed 1 6 4 a method for normalizing infectious dose from donor-to-donor in order to obtain cross-1 6 5 sectional data that was directly comparable (Figure 2A) . For each sample we used 1 6 6 magnetic sorting to isolate untouched naïve B cells, which are a known susceptible cell within the cohort ( Figure 2B ), but was not significantly correlated with age, sex or race 1 7 4 ( Figure 2C ). 1 7 5
Specific targeting of individual B cell lineages by KSHV infection 1 7 6
We next sought to establish the B lymphocyte tropism of KSHV in the human tonsil by 1 7 7 determining which B cell lineages are targeted for KSHV infection at early timepoints. 1 7 8
Because levels of individual B cell lineages are highly variable between samples ( Figure  1  7  9 1B), we represented lineage-specific susceptibility data as the percentage of GFP+ cells 1 8 0 within each lineage so that data could be directly compared cross-sectionally within the 1 8 1 sample cohort. Our analysis of specific B cell lineages targeted for infection by KSHV 1 8 2 revealed that, although they represent a small proportion of the B cells within human 1 8 3 tonsil ( Figure 1B) , CD138+ plasma cells are infected at high frequencies at this early 1 8 4 timepoint. Indeed, CD19+ CD20-plasma cells displayed the highest within-lineage 1 8 5 susceptibility of any cell type with several replicates showing 100% infection of this 1 8 6 lineage at 3 dpi ( Figure 3A ). Other B cell lineages were susceptible to infection, but 1 8 7
were infected at relatively low within-population frequencies compared to plasma cells 1 8 8 ( Figure 3A&B ). Most B cell lineages showed linear correlation between within-lineage 1 8 9 infection and overall infection, while others like plasmablast, double negative, and 1 9 0 CD20-plasma cells showed no correlation to overall infection ( Figure 3B ). Pairwise 1 9 1 correlations revealed no significant effect of the baseline (pre-infection) frequency of 1 9 2 any B cell lineage on the susceptibility of that lineage to KSHV infection, indicating that 1 9 3 the B lymphocyte tropism of KSHV is dependent on cell-intrinsic factors and is not 1 9 4 simply a function of lineage population frequency ( Figure 3C ). 1 9 5
Taken together, our data demonstrate that (1) tonsil lymphocyte specimens are 1 9 6 immunologically heterogeneous, (2) susceptibility of tonsil lymphocytes to ex vivo KSHV 1 9 7 infection is highly donor-dependent and (3) diverse B cell lineages are specifically 1 9 8 targeted by KSHV early in infection. In particular, these data identify CD20-CD138+ 1 9 9 plasma cells as a uniquely susceptible cell type for early KSHV infection in human 2 0 0 tonsil. 2 0 1
CD138 as an attachment factor for KSHV infection of plasma cells 2 0 2
Previous studies have shown that heparin sulfate proteoglycans (HSPG) of the 2 0 3 syndecan family can serve as an attachment factor facilitating KSHV entry via 2 0 4 interaction with the gH/gL glycoprotein complex (Hahn et al., 2009) . In order to test 2 0 5 whether the high susceptibility of tonsil-derived plasma cells was due to increased 2 0 6 attachment via CD138 (syndecan-1), we attempted to selectively neutralize KSHV entry 2 0 7 by pre-treating cell-free virus particles with soluble recombinant CD138 (srCD138) 2 0 8 protein prior to infection. These experiments revealed a small, reproducible decrease in 2 0 9 overall KSHV infection of B lymphocytes with srCD138 treatment ( Figure 4A) Figure 4B ). Moreover, KSHV infection of human fibroblasts was slightly decreased by 2 1 4 srCD138 treatment in 4 of 6 replicates ( Figure 4C ). Taken together, these results 2 1 5 suggest that, although srCD138 seems to weakly inhibit KSHV infection overall, the 2 1 6 effect is not B cell specific. Although plasma cell infection was inhibited by srCD138 in 2 1 7 some samples, the inconsistency between samples indicates that other factors exist 2 1 8 which influence plasma cell targeting and the high susceptibility of plasma cells in our 2 1 9 infection model cannot be explained by the use of plasma cell-expressed CD138 as an 2 2 0 attachment factor for KSHV entry. Therefore, we wanted to determine whether the immunological composition of the tonsil 2 2 6 lymphocyte environment would affect the establishment of KSHV infection in B 2 2 7 lymphocytes and specifically whether overall susceptibility or targeting of particular B 2 2 8 cell lineages is influenced by the presence or absence of T cells. Like B cell lineages, 2 2 9 levels of CD4+ and CD8+ T cell lineages vary considerably between tonsil donors 2 3 0 (Supplemental Figure 2A) . However, unlike B lymphocyte subsets, the distribution of T 2 3 1 cell subsets are not generally correlated with donor age (Supplemental Figure 2B) . 2 3 2
Moreover, CD4/CD8 T cell ratios are not correlated with donor age or overall 2 3 3 susceptibility of tonsil B lymphocytes to KSHV infection (Supplemental Figure 2C) . 2 3 4
To determine whether manipulating the T cell environment would affect KSHV infection 2 3 5 in individual tonsil samples, we chose 11 samples with varying CD4/CD8 T cell ratios 2 3 6 and performed KSHV infections in which total lymphocytes, CD4-depleted total 2 3 7 lymphocytes or CD8-depleted total lymphocytes were added back following infection of fractions is plotted against the baseline CD4/CD8 T cell ratio, we observe that KSHV 2 4 6 infection increased when depletions were performed in samples with high baseline 2 4 7 levels of CD4+ T cells ( Figure 5B ). We next analyzed the effect of T cell depletion on 2 4 8 KSHV infection of specific B cell lineages ( Figure 5C ). These data reveal that depletion 2 4 9 of CD4+ T cells increases infection of plasma cells as well as MZ-like and Transitional B 2 5 0 cell lineages and that the effect is dependent upon the baseline CD4/CD8 T cell ratio in 2 5 1
